# Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis

> **NCT02669238** · PHASE2,PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de la Réunion** · enrollment: 2 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DEVICE:** Nexplanon®
- **DRUG:** Minidril®/Leeloo®

## Key facts

- **NCT ID:** NCT02669238
- **Lead sponsor:** Centre Hospitalier Universitaire de la Réunion
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-25
- **Primary completion:** 2019-10-10
- **Final completion:** 2019-10-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** insufficient recruitment
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669238, "Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02669238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*